Cardiac hypertrophy in diabetic spontaneously hypertensive rats: role of angiotensin II?
MJ Black, T Briscoe, JF Bertram… - Clinical and …, 1997 - Wiley Online Library
In the present study the role of angiotensin II (AngII) in the development of cardiac
hypertrophy in diabetes combined with hypertension was investigated. 2. Diabetes was …
hypertrophy in diabetes combined with hypertension was investigated. 2. Diabetes was …
[HTML][HTML] Effect of telmisartan on the regression of the left ventricular hypertrophy in the patients of essential hypertension
KH Misra, MC Das, YR Ramani - Journal of clinical and diagnostic …, 2013 - ncbi.nlm.nih.gov
Introduction: An increase in the Left Ventricular Mass as a result of muscle hypertrophy, has
emerged as a powerful pressure independent risk factor for the cardiovascular mortality and …
emerged as a powerful pressure independent risk factor for the cardiovascular mortality and …
Effect of banxia baizhu tianma decoction on the left ventricular hypertrophy of hypertrophied myocardium in spontaneously hypertensive rat
JY Jiang, XZ Wang, SS Luo - Zhongguo Zhong xi yi jie he za zhi …, 2010 - europepmc.org
Objective To investigate the changes in renin angiotensin system (RAS) in hypertrophied
myocardium of spontaneous hypertensive rat (SHR), and the effect of Banxia Baizhu Tianma …
myocardium of spontaneous hypertensive rat (SHR), and the effect of Banxia Baizhu Tianma …
Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKCε and PKCβ
K Inagaki, Y Iwanaga, N Sarai, Y Onozawa… - Journal of molecular and …, 2002 - Elsevier
K. Inagaki, Y. Iwanaga, N. Sarai, Y. Onozawa, H. T akenaka, D. Mochly-Rosen and Y.
Kihara. Tissue Angiotensin II During Progression of Ventricular Hypertrophy to Heart Failure …
Kihara. Tissue Angiotensin II During Progression of Ventricular Hypertrophy to Heart Failure …
Effects of valsartan and enalapril on regression of left ventricular hypertrophy in patients with mild to moderate hypertension: a randomized, double-blind study
S Nalbantgil, H Yilmaz, C Gurun, F Özerkan… - Current therapeutic …, 2000 - Elsevier
OBJECTIVE: This study was undertaken to compare the effects of valsartan with those of
enalapril on regression of left ventricular hypertrophy in patients with mild to moderate …
enalapril on regression of left ventricular hypertrophy in patients with mild to moderate …
Effects of m-nifedipine on left ventricular diastolic function and Ca2+ content of myocardial and cerebral mitochondria and artery tissues in left ventricular …
T Xi, MR Rao - Yao xue xue bao= Acta Pharmaceutica Sinica, 1995 - europepmc.org
Left ventricular hypertrophy (LVH) was induced by renal hypertension in rats. m-Nifedipine
(m-Nif, ig 20 mg. kg-1. d-1 for 9 wk) decreased LV weight in the renovascular hypertensive …
(m-Nif, ig 20 mg. kg-1. d-1 for 9 wk) decreased LV weight in the renovascular hypertensive …
Effect of nicardipine treatment upon cardiac hypertrophy in spontaneously hypertensive rats: a morphometric and ultrastructural study
F Ferrante, E Bronzetti, E Ciriaco, L Felici… - Journal of …, 1992 - journals.lww.com
Objective: The present study was designed to investigate the effect of nicardipine
administration upon systolic blood pressure (SBP) and cardiac hypertrophy in …
administration upon systolic blood pressure (SBP) and cardiac hypertrophy in …
The initial stage of left ventricular hypertrophy in spontaneously hypertensive rats is manifested by a decrease in the QRS amplitude/left ventricular mass ratio
L Bacharova, J Kyselovic, J Klimas - Clinical and Experimental …, 2004 - Taylor & Francis
In this study we tested the hypothesis of the relative voltage deficit, ie the discrepancy
between increased left ventricular mass (LVM) and QRS amplitudes, in an experimental …
between increased left ventricular mass (LVM) and QRS amplitudes, in an experimental …
Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats
N Makino, M Sugano, S Otsuka, T Hata - Hypertension, 1997 - Am Heart Assoc
We administered angiotensin (Ang) II receptor type 1 (AT1) blockade (losartan; 10 or 40
mg/kg per day), type II receptor (AT2) blockades (PD123319; 100 mg/kg per day), or …
mg/kg per day), type II receptor (AT2) blockades (PD123319; 100 mg/kg per day), or …
Candesartan, an angiotensin II receptor blocker, improves left ventricular hypertrophy and insulin resistance
F Anan, N Takahashi, T Ooie, M Hara, H Yoshimatsu… - Metabolism, 2004 - Elsevier
A growing body of evidence indicates that the renin-angiotensin system and insulin
resistance play crucial roles in left ventricular hypertrophy (LVH) in patients with essential …
resistance play crucial roles in left ventricular hypertrophy (LVH) in patients with essential …